Searchable abstracts of presentations at key conferences in endocrinology

ea0032p756 | Obesity | ECE2013

Circulating endocannabinoids are differentially modulated during the oral glucose tolerance test

Fanelli Flaminia , Garelli Silvia , Mezzullo Marco , Di Dalmazi Guido , Ponti Federico , Manso Jacopo , Benetta Elisa Dalla , Bazzocchi Alberto , Vicennati Valentina , Battista Giuseppe , Pasquali Renato , Pagotto Uberto

The endocannabinoid system (ECS) is involved in the regulation of food intake and energy expenditure. Increased level of EC lipid mediators anandamide (AEA) and 2-arachydonoylglycerol (2AG) and/or a higher expression of cannabinoid receptor type 1 in central and peripheral districts are supposed to contribute to the development and maintenance of obesity and related dismetabolism. To understand the ECS response to insulin signal and to anthropometric and biochemical parameters...

ea0032p1081 | Thyroid cancer | ECE2013

A novel multi-target pyrazolopyrimidine derivative with anti-neoplastic properties, CLM29, is active against medullary thyroid cancer in vitro and in vivo

Fallahi Poupak , Ferrari Silvia Martina , Bocci Guido , La Motta Concettina , Ruffilli Ilaria , Di Domenicantonio Andrea , Corrado Alda , Mancusi Caterina , Danesi Romano , Da Settimo Federico , Miccoli Paolo , Antonelli Alessandro

Introduction: CLM29, a pyrazolo[3,4-d]pyrimidine compound, inhibits several targets (including the RET tyrosine kinase, epidermal growth factor receptor, vascular endothelial growth factor receptor and has an anti-angiogenic effect). Recently it has been shown to inhibit proliferation and migration in primary papillary dedifferentiated thyroid cancer cells. The aim of this study is to evaluate the anti-tumor activity of CLM29 in medullary thyroid cancer (MTC).<p c...

ea0032p1140 | Thyroid cancer | ECE2013

Ultrasonographic signs suggestive of malignancy in thyroid nodules

Molero Inmaculada Gonzalez , Vallejo-Mora Rosario , Dominguez-Lopez Marta , Romero Stella Gonzalez , Torres Francisca Garcia , de Adana Marisol Ruiz , Soriguer Federico

Introduction: Thyroid ultrasound is a widely used tool in monitoring thyroid nodule, allowing us to assess the size and other sonographic signs suspicious of malignancy, facilitating decisions about diagnosis and treatment.Objectives: To evaluate the presence of ultrasonographic signs suggestive of malignancy in patients with thyroid carcinoma in our hospital.Material and methods: Retrospective study of 63 patients with thyroid car...

ea0028p236 | Pituitary | SFEBES2012

Evaluation of the expression of vesicular protein (SNARE) isoforms in human pituitary adenomas

Garcia Edwin , Trivellin Giampaolo , Michael Powell , Grieve Joan , Sabin Ian , Alusi Ghassan , Louis Pobereskin , Shariati Babak , Roncaroli Federico , Mendoza Nigel , Grossman Ashley , Harper Elaine , Korbonits Marta

Background: Botulinum neurotoxin inhibits muscle function by interfering with neurotransmitter release from secretory vesicles. The mechanism underlying this effect involves cleavage of SNARE proteins which are required for vesicle docking at the plasma membrane. The ability of botulinum neurotoxin serotypes to cleave SNARE proteins and inhibit secretion is being exploited for therapeutic purposes by Syntaxin Ltd with their ‘targeted secretion inhibitor technology’ (...

ea0022p151 | Cardiovascular endocrinology and lipid metabolism | ECE2010

Is obesity a further cardiovascular risk factor in patients with erectile dysfunction?

Corona Giovanni , Monami Matteo , Boddi Valentina , Daniela Balzi , Melani Cecilia , Federico Nelli , Sforza Alessandra , Rotella Carlo , Forti Gianni , Mannucci Edoardo , Maggi Mario

Introduction: Erectile dysfunction (ED) and, in particular, arteriogenic ED have been proposed as new markers of risk for incident major adverse cardiovascular events (MACE). Reduced penile blood flow is more common in obese people than in leaner ED subjects. The aim of this study is to explore the interaction of overweight/obesity and penile blood flow in the prediction of incident MACE.Methods: This is an observational prospective cohort study evaluati...

ea0016s14.2 | Basic highlights | ECE2008

Dopamine receptor 2 activation reduces cells viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion

Zatelli Maria Chiara , Tagliati Federico , Luchin Andrea , Ambrosio Maria Rosaria , Cimino Vincenzo , Bondanelli Marta , Scanarini Massimo , Maira Giulio , De Marinis Laura , degli Uberti Ettore

Dopamine (DA) therapy of non-functioning pituitary adenomas (NFA) can result in tumor stabilization and shrinkage. However, this effect is not always apparent and the mechanism of action is still unknown. Previous evidence showed that DA inhibits pituitary Vascular Endothelial Growth Factor expression (VEGF), that, in turn, is related to pituitary tumor growth. Our study aimed at clarifying whether VEGF secretion modulation might mediate the effects of DA agonists and chimeric...

ea0014oc3.1 | Endocrine tumors &amp; neoplasia | ECE2007

Multiple somatostatin receptor subtypes activation reduces cell viability in non-functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion

Zatelli Maria Chiara , Piccin Daniela , Tagliati Federico , Ambrosio Maria Rosaria , Bianchi Antonio , Bondanelli Marta , Schmid Herbert A , Scanarini Massimo , Marinis Laura De , Maira Giulio , Uberti Ettore C degli

Somatostatin (SRIF) analogs have been employed in medical therapy of non-functioning pituitary adenomas (NFA), with contrasting results. Previous evidence showed that SRIF can exert its antiproliferative effects by reducing Vascular Endothelial Growth Factor (VEGF) secretion and action, and that VEGF expression may be related to pituitary tumor growth. The aim of our study was to clarify the possible effects of a multireceptor SRIF ligand on VEGF secretion and cell proliferati...

ea0014oc3.6 | Endocrine tumors &amp; neoplasia | ECE2007

ERß-specific transcriptional profile in colon cancer

Martineti Valentina , Mascherini Massimiliano , Mavilia Carmelo , Sala Silvia Carbonell , Tognarini Isabella , Azzari Chiara , Stefanini Federico Mattia , Tonelli Francesco , Brandi Maria Luisa

Epidemiological data clearly evidence a protective role of estrogens against the development of colon cancer and ERβ has been identified as the predominant ER subtype in human colon. More recently it has been identified as a favourable prognostic marker in this disease, possibly explaining the protective effect of estrogens against colon cancer development. To understand the specific role and mechanism of action of ERβ in colon tumorigenesis we developed an in vit...

ea0056oc9.1 | Thyroid from basics to clinics | ECE2018

Increased urinary iodide precedes hypothyroidism in Dehal1 knockout mice

Gonzalez-Guerrero Cristian , Lucia Federico S. , Alcaina Yago , Gonzalez-Lopez Ana M. , Buno Antonio , Mora Roberto , De Miguel Maria Paz , Moreno Jose C.

Thyroid hormones (TH) synthesis requires iodine, a scarce element whose recycling is mediated by the iodotyrosine dehalogenase (encoded by the DEHAL1 gene) through deiodination of mono- and di-iodotyrosines. In humans, biallelic mutations in DEHAL1 lead to a severe form of congenital hypothyroidism (CH) non detectable by neonatal screening programs, which involves the risk of mental retardation. The timing and triggering factors of this particular type of hyp...

ea0056p637 | Developmental endocrinology | ECE2018

Effect of desacyl ghrelin on protein expression of GHS-R1 receptor in human placental cells

de la Luz Jaramillo-Narvaez Maria , Guadalupe Leon-Verdin Ma. , Martinez Montes Federico , Luisa Lazo de la Vega Monroy Maria , Barbosa Sabanero Gloria

Introduction: Ghrelin is an orexigenic hormone with two isoforms: Acyl Ghrelin (AG) and Desacyl Ghrelin (DAG). AG binds to its specific receptor GHS-R1 and stimulates growth hormone secretion. DAG also binds to GHS-R1 receptor, but with 1000 times less affinity than AG. Effect of DAG on cell proliferation and inhibition of apoptosis has been reported. However, there are no studies of DAG function in human placenta. For first time, this work analyzed the effect of DAG on viabil...